Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Oncology Reports|June 11, 2019
Targeting lactate dehydrogenase‑A promotes docetaxel‑induced cytotoxicity predominantly in castration‑resistant prostate cancer cellsHiroyuki Muramatsu, Makoto Sumitomo, Shingo Morinaga, et al.Journal of Medical Case Reports|August 4, 2021
Primary leiomyoma of the ureter: a case reportShingo Morinaga, Shigeyuki Aoki, Motoi Tobiume, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 20, 2017
Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitisKogenta Nakamura, Kazuro Ikawa, Genya Nishikawa, et al.Anticancer Research|November 14, 2013
Management of adverse events in patients with metastatic renal cell carcinoma treated with sunitinib and clinical outcomesMaki Arakawa-Todo, Takahiko Yoshizawa, Kenji Zennami, et al.The Prostate|August 8, 2019
Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosisMasahito Watanabe, Kent Kanao, Susumu Suzuki, et al.Experimental and Therapeutic Medicine|September 21, 2012
Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical dataYoshiaki Yamada, Katsuya Naruse, Kogenta Nakamura, et al.Journal of Medical Case Reports|February 5, 2021
Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case reportMotoi Tobiume, Shigeyuki Aoki, Genya Nishikawa, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 8, 2015
Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamicsIkuo Kobayashi, Kazuro Ikawa, Kogenta Nakamura, et al.Experimental and Therapeutic Medicine|September 15, 2012
Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effectMaki Arakawa, Kogenta Nakamura, Yoshiaki Yamada, et al.Cancer Chemotherapy and Pharmacology|March 12, 2009
Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urotheliumYoshiaki Yamada, Youko Itoh, Shigeyuki Aoki, et al.Pageof 3